Trials / Terminated
TerminatedNCT03451123
FET-PET/MRI for Surgical Assessment of Pediatric Brain Tumors
- Status
- Terminated
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- University of Alabama at Birmingham · Academic / Other
- Sex
- All
- Age
- 6 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objectives of this study are: 1. Determine the percentage of patients whose surgical plan would change with FET-PET/MRI compared to MRI alone. 2. Determine the percentage of patients who have residual tumor after surgery detected with FET-PET/MRI. A secondary objective of this study is: 1\) Perform preliminary correlations between the pre- and post-surgical metabolic tumor volumes measured with FET-PET/MRI to progression free survival.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FET PET/MRI | FET PET/MRI scan before and after surgery |
Timeline
- Start date
- 2018-04-23
- Primary completion
- 2023-08-29
- Completion
- 2023-08-29
- First posted
- 2018-03-01
- Last updated
- 2023-12-19
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03451123. Inclusion in this directory is not an endorsement.